Dr. Schaninger is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
740 Rose St
Lexington, KY 40536Phone+1 859-323-5544Fax+1 859-257-9286
Education & Training
- University of Kentucky College of MedicineResidency, Internal Medicine, 2001 - 2004
- OtherClass of 1988
Certifications & Licensure
- KY State Medical License 2006 - 2025
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2013
Clinical Trials
- Extended Steroid in Use in Community Acquired Pneumonia (CAP)(e) Start of enrollment: 2012 Jan 09
Publications & Presentations
PubMed
- Predictors of engagement in screening for a hepatitis C virus (HCV) treatment trial in a rural Appalachian community.Jennifer R Havens, Michelle R Lofwall, April M Young, Michele Staton, Takako Schaninger
Journal of Viral Hepatitis. 2024-06-01 - 2 citationsEliminating hepatitis C in a rural Appalachian county: protocol for the Kentucky Viral Hepatitis Treatment Study (KeY Treat), a phase IV, single-arm, open-label trial ...Jennifer R. Havens, Takako Schaninger, Hannah Fraser, Michelle R. Lofwall, Michele Staton
BMJ Open. 2021-07-05 - 3 citationsCommunity-acquired methicillin-resistant Staphylococcus aureus prostatic abscesses.Prashanth Krishnamohan, Takako Schaninger, Larry M. Baddour, Majdi N. Al-Hasan
The American Journal of the Medical Sciences. 2013-10-01
Press Mentions
- There Is No Vaccine for Hepatitis C — Getting Tested Could Save Your LifeNovember 21st, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: